The country of origin of spinal and epidural needles
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated June 12, 2025, you requested a country of origin ruling. A sample of a spinal needle (SN22G351, 22G x 3.5”) and a sample of an epidural needle (TUFW17G351, 17G x3.5”, Tuohy – Fixed Wing Needle) were received, examined, and disposed of. The spinal needle and epidural needle are used to inject local anesthetics into a patient to provide regional anesthesia.
Each needle consists of a stainless-steel shaft with a bevel (you refer to it as a cannula), a stainless-steel stylet, a plastic cannula hub, a plastic stylet hub, and a needle protector. You describe the manufacturing process as follows: 1. Production in Japan: Stainless-steel hollow tubes are cut to length and sharpened to form the cannula. Some cannulas are etched with depth markings to indicate insertion depth. A silicone coating is applied to the cannula surface.
The blunt end of the cannula is sand-blasted to enhance adhesion to the plastic hub. The stylet is manufactured from solid stainless-steel wire using a similar process. All of the above processes, including the sourcing of raw materials for the cannula and stylet, are performed in Japan. 2. Assembly in China: The Japanese-origin cannula and stylet are exported to China. Plastic hubs, sourced from either China or Japan, are affixed to the cannula and stylet using adhesive glue of Japanese origin.
A needle protector, molded in China using Japanese raw materials, is assembled onto the cannula. The completed needles are packaged in units of 100, placed in plastic bags, and then boxed in cardboard cartons. Both the plastic bags and cardboard boxes are sourced in China. When determining the country of origin, the substantial transformation analysis is applicable. See, e.g., Headquarters Ruling Letter (“HQ”) H301619, dated November 6, 2018.
The test for determining whether a substantial transformation will occur is whether an article emerges from a process with a new name, character, or use different from that possessed by the article prior to processing. See Texas Instruments Inc. v. United States, 681 F.2d 778 (C.C.P.A. 1982). This determination is based on the totality of the evidence. See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff’d, 989 F.2d 1201 (Fed. Cir. 1993).
Based on the information provided, the assembly operation occurring in China is a minor process. The Japanese cannulas and stylets do not substantially transform into new articles of commerce. They retain their own identity having the same name, character, and use after the assembly. Accordingly, we find the country of origin for the spinal and epidural needles is Japan. The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request.
This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N350152).